Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment.
Read More…
Industry, Sector and Symbol
Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Phone650-493-4000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$3.23 billion
Profitability
Miscellaneous
Employees10,062
Next Earnings Date1/29/2020 (Confirmed)
OptionableOptionable
Varian Medical Systems (NYSE:VAR) Frequently Asked Questions
What is Varian Medical Systems' stock symbol?
Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."
How were Varian Medical Systems' earnings last quarter?
Varian Medical Systems, Inc. (NYSE:VAR) announced its quarterly earnings results on Wednesday, October, 23rd. The medical equipment provider reported $1.21 EPS for the quarter, meeting the Zacks' consensus estimate of $1.21. The medical equipment provider earned $878.90 million during the quarter, compared to analyst estimates of $858.47 million. Varian Medical Systems had a net margin of 9.65% and a return on equity of 24.48%. Varian Medical Systems's quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.16 EPS. View Varian Medical Systems' Earnings History.
When is Varian Medical Systems' next earnings date?
How can I listen to Varian Medical Systems' earnings call?
Varian Medical Systems will be holding an earnings conference call on Wednesday, January 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What guidance has Varian Medical Systems issued on next quarter's earnings?
Varian Medical Systems updated its FY 2020
Pre-Market earnings guidance on Monday, November, 25th. The company provided earnings per share (EPS) guidance of $5.30-5.45 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.40. The company issued revenue guidance of $$3.515-3.612 billion, compared to the consensus revenue estimate of $$3.57 billion.
What price target have analysts set for VAR?
6 brokerages have issued twelve-month price objectives for Varian Medical Systems' shares. Their forecasts range from $152.00 to $165.00. On average, they expect Varian Medical Systems' share price to reach $159.33 in the next year. This suggests a possible upside of 9.5% from the stock's current price. View Analyst Price Targets for Varian Medical Systems.
What is the consensus analysts' recommendation for Varian Medical Systems?
6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Varian Medical Systems in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Varian Medical Systems.
What are Wall Street analysts saying about Varian Medical Systems stock?
Here are some recent quotes from research analysts about Varian Medical Systems stock:
- 1. According to Zacks Investment Research, "Varian continues to gain from its core Oncology Systems segment, which saw solid growth, especially in EMEA and China. In fact, management foresees tremendous opportunities in China owing to the recent tariff exclusions. Gross orders surged in the quarter. Management is optimistic about the recently-closed acquisitions of CyberHeart, Cancer Treatment Services International, Endocare and Alicon. A solid guidance for fiscal 2020 paints a bright picture as well. Expansion in gross and operating margins is an added positive. The stock has outperformed the industry in a year’s time. Varian exited the fiscal fourth quarter on a strong note. On the flip side, the Proton Solutions unit saw a soft quarter. Moreover, Varian’s APAC revenues were hurt by headwinds in Japan." (1/20/2020)
- 2. Barrington Research analysts commented, "We strongly suspect that radiation that is delivered via the Ethos system will receive very high marks from both clinicians and patients alike. Ethos currently has its CE Mark while a 510(k) regulatory clearance in the U.S. is still pending." (9/23/2019)
Has Varian Medical Systems been receiving favorable news coverage?
Press coverage about VAR stock has been trending somewhat negative this week, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Varian Medical Systems earned a news impact score of -1.4 on InfoTrie's scale. They also assigned headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Varian Medical Systems.
Are investors shorting Varian Medical Systems?
Varian Medical Systems saw a drop in short interest in the month of January. As of January 15th, there was short interest totalling 1,660,000 shares, a drop of 15.7% from the December 31st total of 1,970,000 shares. Based on an average daily volume of 627,300 shares, the short-interest ratio is presently 2.6 days. Currently, 1.8% of the shares of the company are sold short. View Varian Medical Systems' Current Options Chain.
Who are some of Varian Medical Systems' key competitors?
Some companies that are related to Varian Medical Systems include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hologic (HOLX), Steris (STE) and Insulet (PODD).
What other stocks do shareholders of Varian Medical Systems own?
Who are Varian Medical Systems' key executives?
Varian Medical Systems' management team includes the folowing people:
- Mr. Dow R. Wilson, Pres, CEO & Director (Age 60)
- Mr. Gary E. Bischoping Jr., Sr. VP of Fin. & CFO (Age 51)
- Mr. John W. Kuo, Sr. VP, Gen. Counsel & Corp. Sec. (Age 56)
- Ms. Kolleen T. Kennedy, Chief Growth Officer & Pres of Proton Solutions (Age 60)
- Mr. Kevin O'Reilly, Sr. VP of Global Operations
Who are Varian Medical Systems' major shareholders?
Varian Medical Systems' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Boston Trust Walden Corp (0.52%), California Public Employees Retirement System (0.24%), DNB Asset Management AS (0.15%), Zurcher Kantonalbank Zurich Cantonalbank (0.14%), New York State Teachers Retirement System (0.12%) and Culbertson A N & Co. Inc. (0.05%). Company insiders that own Varian Medical Systems stock include Christopher A Toth, David J Illingworth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, Mark R Laret, R Andrew Eckert, Susan L Bostrom and Timothy E Guertin. View Institutional Ownership Trends for Varian Medical Systems.
Which institutional investors are selling Varian Medical Systems stock?
VAR stock was sold by a variety of institutional investors in the last quarter, including DNB Asset Management AS, State of Alaska Department of Revenue, Arizona State Retirement System, New York State Teachers Retirement System, Nisa Investment Advisors LLC, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Strs Ohio and Culbertson A N & Co. Inc.. Company insiders that have sold Varian Medical Systems company stock in the last year include Christopher A Toth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, R Andrew Eckert and Timothy E Guertin. View Insider Buying and Selling for Varian Medical Systems.
Which institutional investors are buying Varian Medical Systems stock?
VAR stock was bought by a variety of institutional investors in the last quarter, including Zurcher Kantonalbank Zurich Cantonalbank, Johanson Financial Advisors Inc., Assenagon Asset Management S.A., California Public Employees Retirement System, Virginia Retirement Systems ET AL, Boston Trust Walden Corp, Tower View Investment Management & Research LLC and We Are One Seven LLC. View Insider Buying and Selling for Varian Medical Systems.
How do I buy shares of Varian Medical Systems?
Shares of VAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Varian Medical Systems' stock price today?
One share of VAR stock can currently be purchased for approximately $145.55.
How big of a company is Varian Medical Systems?
Varian Medical Systems has a market capitalization of $13.23 billion and generates $3.23 billion in revenue each year. The medical equipment provider earns $291.90 million in net income (profit) each year or $4.63 on an earnings per share basis. Varian Medical Systems employs 10,062 workers across the globe.View Additional Information About Varian Medical Systems.
What is Varian Medical Systems' official website?
How can I contact Varian Medical Systems?
Varian Medical Systems' mailing address is 3100 Hansen Way, Palo Alto CA, 94304. The medical equipment provider can be reached via phone at 650-493-4000 or via email at [email protected]
MarketBeat Community Rating for Varian Medical Systems (NYSE VAR)
MarketBeat's community ratings are surveys of what our community members think about Varian Medical Systems and other stocks. Vote "Outperform" if you believe VAR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VAR will underperform the S&P 500 over the long term. You may vote once every thirty days.
